Glycogen storage disease type I epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The [[incidence]] of glycogen storage disease type 1 (GSD 1) is approximately 1 per 100,000 individuals worldwide.The [[prevalence]] of glycogen storage disease type 1 is approximately 5 per 100,000 individuals in Ashkenazi Jewish population. Glycogen storage disease type 1 is usually first diagnosed among [[infants]]. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== |
Revision as of 17:28, 27 November 2017
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I epidemiology and demographics |
FDA on Glycogen storage disease type I epidemiology and demographics |
CDC on Glycogen storage disease type I epidemiology and demographics |
Glycogen storage disease type I epidemiology and demographics in the news |
Blogs on Glycogen storage disease type I epidemiology and demographics |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
The incidence of glycogen storage disease type 1 (GSD 1) is approximately 1 per 100,000 individuals worldwide.The prevalence of glycogen storage disease type 1 is approximately 5 per 100,000 individuals in Ashkenazi Jewish population. Glycogen storage disease type 1 is usually first diagnosed among infants.
Epidemiology and Demographics
Incidence
- The incidence of glycogen storage disease type 1 (GSD 1) is approximately 1 per 100,000 individuals worldwide.[1][2]
- 80% Cases of GSD 1 are of GSD type 1a.
Prevalence
- The prevalence of glycogen storage disease type 1 is approximately 5 per 100,000 individuals in Ashkenazi Jewish population.[3][4]
Age
Race
- Glycogen storage disease type 1 usually affects individuals of the Ashkenazi Jewish population.[3][5]
Gender
- Glycogen storage disease type 1 affects men and women equally.[6]
References
- ↑ Mansfield BC (1999). "Molecular Genetics of Type 1 Glycogen Storage Diseases". Trends Endocrinol Metab. 10 (3): 104–113. PMID 10322403.
- ↑ "glycogen storage disease type I - Genetics Home Reference".
- ↑ 3.0 3.1 3.2 Kishnani, Priya S.; Austin, Stephanie L.; Abdenur, Jose E.; Arn, Pamela; Bali, Deeksha S.; Boney, Anne; Chung, Wendy K.; Dagli, Aditi I.; Dale, David; Koeberl, Dwight; Somers, Michael J.; Burns Wechsler, Stephanie; Weinstein, David A.; Wolfsdorf, Joseph I.; Watson, Michael S. (2014). "Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics". Genetics in Medicine. doi:10.1038/gim.2014.128. ISSN 1098-3600.
- ↑ Bali DS, Chen YT, Austin S, et al. Glycogen Storage Disease Type I. 2006 Apr 19 [Updated 2016 Aug 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1312/
- ↑ Bali DS, Chen YT, Austin S, et al. Glycogen Storage Disease Type I. 2006 Apr 19 [Updated 2016 Aug 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1312/
- ↑ Bali DS, Chen YT, Austin S, et al. Glycogen Storage Disease Type I. 2006 Apr 19 [Updated 2016 Aug 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1312/